Filed: 11/14/2024ACC: 0000898432-24-000922
π What this filing means
GATES FOUNDATION filed this quarterly 13FβHR report disclosing 5 equity positions with a total reported market value of $43.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$43.50M
Total AUM (reported)
5.88M
Total Shares
Allocation by class
SPONSORED ADS$17.66M40.6%
COM$16.29M37.4%
ADS$7.76M17.8%
COM CL A$1.79M4.1%
Portfolio Concentration
Top 3$37.10M85.3%
4β10$6.40M14.7%
Top 3 weight
85.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.88M
Sole
Full voting authority
5.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings5
Rows:
BIONTECH SE
SOLEShares148.67K
TypeSH
Market value$17.66M
40.59%
Sole
148.67K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares1.56M
TypeSH
Market value$11.68M
26.84%
Sole
1.56M
Shared
0.00
None
0.00
EXSCIENTIA
SOLEShares1.59M
TypeSH
Market value$7.76M
17.85%
Sole
1.59M
Shared
0.00
None
0.00
CUREVAC N V
SOLEShares1.57M
TypeSH
Market value$4.61M
10.60%
Sole
1.57M
Shared
0.00
None
0.00
BUTTERFLY NETWORK INC
SOLEShares1.01M
TypeSH
Market value$1.79M
4.11%
Sole
1.01M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIONTECH SESOLE | SPONSORED ADS | 148.67K | SH | $17.66M 40.59% | 148.67K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 1.56M | SH | $11.68M 26.84% | 1.56M | 0.00 | 0.00 |
EXSCIENTIASOLE | ADS | 1.59M | SH | $7.76M 17.85% | 1.59M | 0.00 | 0.00 |
CUREVAC N VSOLE | COM | 1.57M | SH | $4.61M 10.60% | 1.57M | 0.00 | 0.00 |
BUTTERFLY NETWORK INCSOLE | COM CL A | 1.01M | SH | $1.79M 4.11% | 1.01M | 0.00 | 0.00 |